Clinical Trials Directory

Trials / Terminated

TerminatedNCT02199067

Measurement of Exhaled Propofol

Measurement of Exhaled Propofol During a Total Intravenous Anesthesia With Propofol and Remifentanil

Status
Terminated
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
University of Erlangen-Nürnberg Medical School · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Propofol is a common intravenous anaesthetic drug used for anaesthesia induction and for permanent infusion to maintain anaesthesia (total intravenous anaesthesia). Different to the volatile anaesthetics (feedback concentrations in exhaled breathing gas) piloting of an total intravenous anaesthesia with propofol is done only by experience of the anaesthetist or according to pharmacokinetic models. In this study we want to investigate if the exhaled fraction of propofol is a potential measurement parameter for piloting anaesthesia. Exhaled propofol will be measured with an electrochemical sensor developed by "Drägerwerk AG \& Co. KGaA". Exhaled propofol levels will be compared with the corresponding arterial serum concentrations of propofol. Furthermore we investigate the correlation of exhaled propofol levels with the Bispectral Index (BIS).

Conditions

Timeline

Start date
2014-07-01
Primary completion
2018-12-01
Completion
2019-04-01
First posted
2014-07-24
Last updated
2019-04-17

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02199067. Inclusion in this directory is not an endorsement.